Literature DB >> 31260644

Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Chaya S Moskowitz1, Joanne F Chou1, Joseph P Neglia2, Ann H Partridge3, Rebecca M Howell4, Lisa R Diller3, Danielle Novetsky Friedman1, Dana Barnea5, Lindsay M Morton6, Lucie M Turcotte2, Michael A Arnold7, Wendy M Leisenring8, Gregory T Armstrong9, Leslie L Robison9, Kevin C Oeffinger10, Tara O Henderson11.   

Abstract

PURPOSE: Female survivors of childhood cancer have a high risk of subsequent breast cancer. We describe the ensuing risk for mortality and additional breast cancers. PATIENTS AND METHODS: Female participants in the Childhood Cancer Survivor Study, a cohort of 5-year survivors of cancer diagnosed between 1970 and 1986 before age 21 years, and subsequently diagnosed with breast cancer (n = 274; median age at breast cancer diagnosis, 38 years; range, 20 to 58 years) were matched to a control group (n = 1,095) with de novo breast cancer. Hazard ratios (HRs) and 95% CIs were estimated from cause-specific proportional hazards models.
RESULTS: Ninety-two childhood cancer survivors died, 49 as a result of breast cancer. Overall survival after breast cancer was 73% by 10 years. Subsequent risk of death as a result of any cause was higher among childhood cancer survivors than among controls (HR, 2.2; 95% CI, 1.7 to 3.0) and remained elevated after adjusting for breast cancer treatment (HR, 2.4; 95% CI, 1.7 to 3.2). Although breast cancer-specific mortality was modestly elevated among childhood cancer survivors (HR, 1.3; 95% CI, 0.9 to 2.0), survivors were five times more likely to die as a result of other health-related causes, including other subsequent malignant neoplasms and cardiovascular or pulmonary disease (HR, 5.5; 95% CI, 3.4 to 9.0). The cumulative incidence of a second asynchronous breast cancer also was elevated significantly compared with controls (P < .001).
CONCLUSION: Mortality after breast cancer was higher in childhood cancer survivors than in women with de novo breast cancer. This increased mortality reflects the burden of comorbidity and highlights the need for risk-reducing interventions.

Entities:  

Mesh:

Year:  2019        PMID: 31260644      PMCID: PMC6698921          DOI: 10.1200/JCO.18.02219

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  35 in total

1.  Attribution of deaths following cancer treatment.

Authors:  Colin B Begg; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2002-07-17       Impact factor: 13.506

2.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

Authors:  Lisa A Carey; Charles M Perou; Chad A Livasy; Lynn G Dressler; David Cowan; Kathleen Conway; Gamze Karaca; Melissa A Troester; Chiu Kit Tse; Sharon Edmiston; Sandra L Deming; Joseph Geradts; Maggie C U Cheang; Torsten O Nielsen; Patricia G Moorman; H Shelton Earp; Robert C Millikan
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

Review 3.  Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study.

Authors:  Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

4.  The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.

Authors:  Jarrett Rosenberg; Yen Lin Chia; Sylvia Plevritis
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

5.  Second primary breast cancer occurrence according to hormone receptor status.

Authors:  Allison W Kurian; Laura A McClure; Esther M John; Pamela L Horn-Ross; James M Ford; Christina A Clarke
Journal:  J Natl Cancer Inst       Date:  2009-07-09       Impact factor: 13.506

6.  The descriptive epidemiology of second primary breast cancer.

Authors:  Jonine L Bernstein; Robert H Lapinski; Seema S Thakore; John T Doucette; W Douglas Thompson
Journal:  Epidemiology       Date:  2003-09       Impact factor: 4.822

Review 7.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Authors:  Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 8.  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; Qi Liu; Yutaka Yasui; Joseph P Neglia; Wendy Leisenring; Leslie L Robison; Ann C Mertens
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

10.  Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 50.717

View more
  14 in total

1.  Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.

Authors:  Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout
Journal:  Ann Intern Med       Date:  2020-07-07       Impact factor: 25.391

2.  Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.

Authors:  Renée L Mulder; Melissa M Hudson; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Flora E van Leeuwen; Cécile M Ronckers; Tara O Henderson; Chaya S Moskowitz; Danielle N Friedman; Andrea K Ng; Helen C Jenkinson; Charlotte Demoor-Goldschmidt; Roderick Skinner; Leontien C M Kremer; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2020-09-29       Impact factor: 44.544

Review 3.  Cardio-oncology: Implications for Clinical Practice for Women.

Authors:  Seyed Ebrahim Kassaian; Bhumika Gandhi; Ana Barac
Journal:  Curr Cardiol Rep       Date:  2022-09-16       Impact factor: 3.955

4.  Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy.

Authors:  Chengshi Wang; Kejia Hu; Chuanxu Luo; Lei Deng; Katja Fall; Rulla M Tamimi; Unnur A Valdimarsdóttir; Fang Fang; Donghao Lu
Journal:  Br J Cancer       Date:  2021-09-27       Impact factor: 9.075

5.  Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.

Authors:  Kevin C Oeffinger; Kayla L Stratton; Melissa M Hudson; Wendy M Leisenring; Tara O Henderson; Rebecca M Howell; Suzanne L Wolden; Louis S Constine; Lisa R Diller; Charles A Sklar; Paul C Nathan; Sharon M Castellino; Dana Barnea; Susan A Smith; Raymond J Hutchinson; Gregory T Armstrong; Leslie L Robison
Journal:  J Clin Oncol       Date:  2021-02-25       Impact factor: 50.717

6.  Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.

Authors:  Kevin T Lynch; William J Kane; Mark A Fleming; Raj P Desai; Shayna L Showalter; Craig L Slingluff; Daniel E Levin; Traci L Hedrick
Journal:  J Surg Oncol       Date:  2021-03-31       Impact factor: 2.885

7.  A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer.

Authors:  Smita Bhatia; Melanie R Palomares; Lindsey Hageman; Yanjun Chen; Wendy Landier; Kandice Smith; Heidi Umphrey; Caroline A Reich; Kathryn W Zamora; Saro H Armenian; Therese B Bevers; Anne Blaes; Tara Henderson; David Hodgson; Melissa M Hudson; Larissa A Korde; Susan A Melin; Sofia D Merajver; Linda Overholser; Sandhya Pruthi; F Lennie Wong; Judy E Garber
Journal:  Clin Cancer Res       Date:  2020-12-03       Impact factor: 13.801

Review 8.  Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.

Authors:  Amy Trentham-Dietz; Oguzhan Alagoz; Christina Chapman; Xuelin Huang; Jinani Jayasekera; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Jennifer M Yeh; Sylvia K Plevritis; Jeanne S Mandelblatt
Journal:  PLoS Comput Biol       Date:  2021-06-17       Impact factor: 4.475

9.  Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness.

Authors:  Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Grace O'Brien; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Melissa M Hudson; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Paul C Nathan; Joseph P Neglia; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

10.  Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation.

Authors:  Candice A M Sauder; Qian Li; Alisha Othieno; Daisy Cruz; Mili Arora; Richard J Bold; Fredrick J Meyers; Theresa H M Keegan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.